• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFH290523
Device Problem Difficult to Advance (2920)
Patient Problems Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Event Date 10/24/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that a versacross connect access solution was selected for use during a watchman procedure.A pericardial effusion occurred and the procedure was cancelled.During transseptal prominent eustachian valve of the inferior vena cava - ivc was making it difficult to get to the superior vena cava - svc.The physician used the versacross rf wire to advance to the svc, but was unable to advance to it.Then, he inserted the mechanical guidewire and it was unable to get to the svc.A non-boston scientific glidewire was inserted, and it went to the svc via a non-boston mpa2 5fr diagnostic catheter.The diagnostic catheter was removed.The versacross connect and the was double curve sheath were advanced to the svc.The patient pressure started dropping and pressors was given to stabilize the blood pressure.A pericardial effusion was seen on transesophageal echocardiogram (tee) and pericardial tap was then performed.A total of 500ml of fluid was removed from the lateral wall and right atrium.The procedure was cancelled.A drained was left and the patient remained in intensive care unit for two days, fully recovered and was discharged(b)(6) 2023.The device is not expected to be returned for analysis (disposed).In the physician's opinion, the versacross connect contributed to the patient complication, since during attempt to get tsp the eustachian valve was in the way and the physician had difficulty getting up to the svc.The patient was admitted to hospital beyond the standard of care.No pe was noted prior to tsp.The transseptal puncture was not obtained.The patient had no oac on board.The patient was not on antiplatelet drugs at this time.No known medical reason for the pericardial effusion.A versacross rf wire, a mechanical guidewire and a non-boston scientific glidewire were used and pulled down several times.There were difficulties with imagining the anatomy.There was some force used to try to advance the wire and sheath to the svc.The radio frequency was not attempted at all the system was removed and pericardial tap began.No other issues with transseptal devices were noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18187212
MDR Text Key328741337
Report Number2124215-2023-63084
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFH290523
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/06/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age61 YR
Patient SexFemale
Patient RaceWhite
-
-